Good morning, everyone, and welcome to the Freeport conference call. Earlier this morning, FCX reported its fourth-quarter ...

Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...

The portfolio trended higher in Q4 and outperformed the ICE BofA 3-Month U.S. Treasury Bill Index for the period and remains ...

Alphamin’s audited consolidated financial statements and accompanying Management’s Discussion and Analysis for the year and ...

Q4 2024 Earnings Call Transcript January 21, 2025 Netflix, Inc. beats earnings expectations. Reported EPS is $4.27, ...

Inc. reported its fourth-quarter 2024 earnings, surpassing analysts' expectations with an operating earnings per share (EPS) of $0.71 against a forecasted $0.65. Despite the earnings beat, the company ...

Boeing Co. said it incurred nearly $3 billion worth of charges in the fourth quarter of 2024 due to a lengthy labor stoppage, job cuts and problems with a number of government programs ...

CSX has a tough fourth quarter, with revenue and earnings falling short amidst transportation sector challenges.

TriSalus Life Sciences® Inc. (Nasdaq: TLSI), is announcing preliminary unaudited fourth quarter and full year 2024 financial results and details of the upcoming conference call.

Riverwater Partners, an investment management company, released its “Micro Opportunities Strategy” Q4 2024 investor letter.

Greenlight Capital, an investment management firm, released its fourth-quarter 2024 investor letter. In 2024, the Greenlight Capital funds returned 7.2% net of fees and expenses, compared to 25.0% for ...

Johnson & Johnson ( JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to ...